Team:Paris Bettencourt
From 2013.igem.org
(Difference between revisions)
Line 210: | Line 210: | ||
/*position:absolute;*/ | /*position:absolute;*/ | ||
z-index:2; | z-index:2; | ||
- | opacity:0. | + | opacity:0.3; |
- | filter: alpha(opacity= | + | filter: alpha(opacity=30); |
} | } | ||
.titlebox { | .titlebox { | ||
z-index:1; | z-index:1; | ||
position:relative; | position:relative; | ||
- | bottom: | + | bottom:100px; |
background:transparent; | background:transparent; | ||
} | } | ||
.narrowimg:hover { | .narrowimg:hover { | ||
+ | opacity:0.8; | ||
+ | filter: alpha(opacity=80); | ||
} | } | ||
</style> | </style> |
Revision as of 22:10, 22 September 2013
FIGHT TUBERCULOSIS WITH MODERN WEAPONS
Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis affecting millions of people over the world. Using Escherichia coli as a model organism we are developing different approaches that could contribute to the fight against TB.
A biosensor that detects the presence of sequence specific antibiotic resistance genes.
A safe and specific high-throughput drug screening method that targets essential mycobacterial metabolic proteins.
A phage system with low fitness cost producing sRNA, which inhibit the synthesis of antibiotic resistance proteins.
An E. coli which invades macrophages and kills mycobacteria.
Visit our Results!